ARCHIVES

Arimidex Gets Full Approval For HR+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Bioassay Backlog To Be Cleared Up In Year: Squire

November 26, 1976

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

Congress Holds Recision Hearings

February 28, 1975

José Baselga Named Physician-in-Chief Of Memorial Sloan-Kettering Hospital

September 21, 2012

NTP Establishes Panel To Write New Guidelines For Detection, Evaluation Of Chemical Carcinogens

April 1, 1983